Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

Drug Master File and cGMP Assistance

The 21 CFR 211 Subparts below are provided as general information. Within each Subpart, our editors have included the corresponding guidance sections from FDA's Draft Guidance on Manufacturing, Processing, or Holding Active Pharmaceutical Ingredients.

In Subparts 211.80 - 211.94 the CFR addresses "Control of Components and Drug Product Containers and Closures". These are the "raw materials" of a finished product. The corresponding raw material subject matter for API's includes starting materials, intermediates, solvents, mother liquors, second crops, process water, etc.

Title 21--Food and Drugs

CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES

PART 211--CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS

 

Subpart A
General Provisions
211.1Scope.
211.3Definitions.
Subpart B
Organization and Personnel
211.22Responsibilities of quality control unit.
211.25Personnel qualifications.
211.28Personnel responsibilities.
211.34Consultants.
Subpart C
Buildings and Facilities
211.42Design and construction features.
211.44Lighting.
211.46Ventilation, air filtration, air heating and cooling.
211.48Plumbing.
211.50Sewage and refuse.
211.52Washing and toilet facilities.
211.56Sanitation.
211.58Maintenance.
211.63Equipment design, size, and location.
Subpart D
Equipment
211.65Equipment construction.
211.67Equipment cleaning and maintenance.
211.68Automatic, mechanical, and electronic equipment.
211.72Filters.
Subpart E
Control of Components and Drug Product Containers and Closures
211.80General requirements.
211.82Receipt and storage of untested components, drug product containers, and closures.
211.84Testing and approval or rejection of components, drug product containers, and closures.
211.86Use of approved components, drug product containers, and closures.
211.87Retesting of approved components, drug product containers, and closures.
211.89Rejected components, drug product containers, and closures.
211.94Drug product containers and closures.
Subpart F
Production and Process Controls
211.100Written procedures; deviations.
211.101Charge-in of components.
211.103Calculation of yield.
211.105Equipment identification.
211.110Sampling and testing of in-process materials and drug products.
211.111Time limitations on production.
211.113Control of microbiological contamination.
211.115Reprocessing.
Subpart G
Packaging and Labeling Control
211.122Materials examination and usage criteria.
211.125Labeling issuance.
211.130Packaging and labeling operations.
211.132Tamper-evident packaging requirements for over-the-counter (OTC) human drug products.
211.134Drug product inspection.
211.137Expiration dating.
Subpart H
Holding and Distribution
211.142Warehousing procedures.
211.150Distribution procedures.
Subpart I
Laboratory Controls
211.160General requirements.
211.165Testing and release for distribution.
211.166Stability testing.
211.167Special testing requirements.
211.170Reserve samples.
211.173Laboratory animals.
211.176Penicillin contamination.
Subpart J
Records and Reports
211.180General requirements.
211.182Equipment cleaning and use log.
211.184Component, drug product container, closure, and labeling records.
211.186Master production and control records.
211.188Batch production and control records.
211.192Production record review.
211.194Laboratory records.
211.196Distribution records.
211.198Complaint files.
Subpart K
Returned and Salvaged Drug Products
211.204Returned drug products.
211.208Drug product salvaging.


Related Validation…Process Validation Strategy
Validation Protocol
Prospective Validation
Concurrent Validation
Retrospective Validation
Change-Control System
Change-Control Classification
ReprocessingReprocessing by Repeating a Chemical Reaction
Reprocessing by Physical Manipulations
Reworking of APIs and Intermediates

 

Home | Drugs by Generic Name | DMF Index | Search | Site Map

© 2007 Betterchem Corp.